drugset / Trial / NCT03949621
A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy Participants
RandomizedParallel-groupOpen-labelOther
Summary
The purpose of this study is to compare the PK of single dose of vedolizumab SC 108 milligram (mg) administered as PFS vs investigational device.
Timeline
- Start
- 2018-02-06
- Primary completion
- 2018-07-02
- Completion
- 2018-08-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vedolizumab | Monoclonal antibody | 108 mg | Subcutaneous |
Indications
No indication recorded.